BC’s Health Professions and Occupations Act, Now in Effect, Boosts Transparency on Prior Discipline
The British Columbia Health Professions and Occupations Act (HPOA) became law on April 1, 2026, overhauling the province’s health‑care regulatory framework. It requires all disciplinary actions and summary protection orders to appear on public registries, boosting transparency for patients and employers. The legislation also creates an independent oversight office with a new disciplinary tribunal and mandates fully appointed, diverse college boards. Additionally, discrimination is codified as a specific ground for professional misconduct, and a scope‑of‑practice review is slated for late spring 2026.
Confused About the New Cholesterol Guidelines? Here’s What to Know.
New cholesterol guidelines from the American College of Cardiology and partner societies lower the age for proactive management, recommending testing starting at age 19 and a one‑time Lp(a) screen for all adults. Adults should undergo a lipid panel at least every...
AMA CEO Outlines Key Goals As New Digital Health/AI Center Staffs Up
American Medical Association CEO John Whyte announced the staffing of a new Center for Digital Health and AI, positioning it to shape policy as digital medicine expands. The center will convene a meeting next month with a leading digital‑medicine coalition...
GE HealthCare, Medtronic Integrate Intraoperative Ultrasound System and Surgical Navigation System
GE HealthCare announced that its bkActiv intraoperative ultrasound system is now digitally integrated with Medtronic’s Stealth AXiS surgical navigation platform. The plug‑and‑play solution provides real‑time ultrasound imaging alongside pre‑operative MRI or CT, helping surgeons address brain shift during cranial procedures....
Compounding Research
The FDA has launched multiple research collaborations to evaluate the safety and efficacy of compounded drug products. Partnerships with the National Academies of Science, Engineering, and Medicine (NASEM) focus on bioidentical hormone therapy and topical pain cream ingredients, while its...
UMB Sues Public Finance Authority, Addiction Center Manager After 'Collapse'
Bond trustee UMB Bank NA has filed a lawsuit in Indiana seeking a court‑appointed receiver for two addiction‑treatment centers financed with $117 million of tax‑exempt municipal bonds. The suit targets Wisconsin’s Public Finance Authority (PFA) and three healthcare managers, alleging financial...
FDA’s 2026 General Wellness Policy and What It Means for Manufacturers of Wearable Devices
The FDA finalized its General Wellness Policy for low‑risk devices on Jan. 6, 2026, setting clear criteria that wearable products can avoid medical‑device regulation if they are limited to general‑wellness purposes and pose low safety risk. The guidance follows a July 2025 warning...
Luminai Secures $38M, Inks Enterprise AI Partnership with Cleveland Clinic
Luminai announced a $38 million Series B round led by Peak XV Partners, lifting its total capital to $60 million. Simultaneously, the company unveiled an enterprise AI deployment with the Cleveland Clinic to automate the routing of faxed referrals. By embedding hospital‑specific standard operating procedures...
Human Drug Compounding Policies and Rules
The FDA has released a series of guidance documents, interim policies, and Federal Register notices spanning 2014‑2025 that shape human drug compounding under sections 503A and 503B of the FD&C Act. Recent 2025 interim policies address bulk drug substance use for both...
General Atlantic Acquires Home Care Provider TEAM Services For $3B
General Atlantic has completed a $3 billion acquisition of TEAM Services Group, a San Diego‑based home‑care provider, valuing the business at roughly 10 times EBITDA. The transaction, which includes debt, adds a nationwide platform with 100,000 caregivers to General Atlantic’s health‑care portfolio....
Easier Access to GLP-1s Sends Usage Far Beyond Original Predictions
Morgan Stanley Research now projects that 55 million U.S. consumers will be using GLP‑1 drugs by 2035, up from its earlier estimate of 33 million. The surge is driven by Medicare coverage and the introduction of oral formulations. Despite higher discontinuation and...
Sex, Racial Disparities Persist Across Melanoma Care Continuum
Two posters presented at the 2026 American Academy of Dermatology meeting reveal enduring melanoma inequities. Men experience a 50% higher incidence (30.8 vs 19.8 per 100,000) and a 1.43‑fold higher mortality‑to‑incidence ratio than women, with some western counties showing more...
First-Ever WHO Forum Unites 800+ Collaborating Centres for Stronger Scientific Collaboration
The World Health Organization convened its inaugural Global Forum of Collaborating Centres, drawing more than 800 institutions from over 80 countries. Delegates highlighted emerging health threats and pledged to move beyond isolated projects toward integrated, dynamic partnerships. A new Collaborative...
Re: Doctors’ Distinct Work and Professional Role Can’t Be Parcelled Into Generic Tasks for “Tiers” Of Healthcare Staff
Retired GP Ann Bowman wrote to the BMJ in support of a recent article warning against overly generic task‑allocation across healthcare tiers. She acknowledges the pitfalls of "taskification" but points out that resident doctors still perform routine procedures such as...
Recovery Works When Coverage Does: The Lifesaving Impact of Medicare’s IOP Expansion
In 2024 Medicare closed a long‑standing coverage gap by adding an intensive outpatient program (IOP) benefit for mental health and substance‑use disorders, including opioid use disorder. Early data show IOP participants improved their BARC‑10 recovery scores by 4.56 points and...
Meta-Analysis Supports Efficacy, Cost Savings of In-Home Vitiligo Therapy
A new meta‑analysis of four controlled studies confirms that home‑based narrowband UVB phototherapy delivers comparable repigmentation outcomes to traditional in‑office treatment for vitiligo. The analysis, covering 148 patients using home devices and 143 receiving clinic care, found odds ratios of...
Most Health AI Users Don’t Rate Chatbots as Highly Accurate: Poll
A recent Pew poll of over 5,000 U.S. adults shows that while more than 20% occasionally use AI chatbots for health questions, only 18% consider the information very or extremely accurate. By contrast, 65% trust their providers for accurate advice,...
CDC Study Shows COVID Shot Benefits; Trump Official Blocks Release
A CDC‑vetted study found that the 2025‑2026 COVID‑19 vaccine cut urgent‑care visits by roughly 50% and hospitalizations by 55% among healthy adults. The research was slated for publication in the MMWR on March 19 but was halted by acting CDC...
Medline Recalls Millions of Devices Due to Safety Risk—FDA Threatens ‘Regulatory Action’ in Warning Letter
Medline, an Illinois‑based medical supplier that went public in December 2025, is recalling more than 4 million NAMIC angiographic control syringes and over 1 million procedure kits because of a loose‑connection defect that can cause air embolism or clinician exposure. The FDA...
Court Blocks Tennessee From Dictating Employer Pharmacy Benefit Design
A federal appeals court ruled that Tennessee's pharmacy‑benefit‑manager statutes are preempted by ERISA, reaffirming that states cannot control the design of self‑funded health‑plan pharmacy networks. The Sixth Circuit found the laws crossed three of four preemption lines by forcing open...
Talkiatry Launches Talkiatry Connect for Cloud-Based EMR Psychiatric Referrals
Talkiatry, the largest private employer of psychiatrists in the United States, has introduced Talkiatry Connect, a browser‑based overlay that integrates directly with more than 30 cloud‑based EMR systems. The tool places a small icon in the clinician’s workflow; when clicked,...
British Heart Foundation Receives Largest Donation
The British Heart Foundation received a £6 million (≈$7.7 million) donation from the Garfield Weston Foundation, the charity’s largest single gift ever. The money will bolster the BHF’s Centre of Research Excellence in Advanced Cardiac Therapies, a joint venture with the Medical...
Re: Glucagon-Like Peptide-1 Receptor Agonists and Risk of Substance Use Disorders Among US Veterans with Type 2 Diabetes: Cohort Study
A BMJ cohort study emulating a target trial found that US veterans with type 2 diabetes who were prescribed glucagon‑like peptide‑1 (GLP‑1) receptor agonists experienced significantly fewer incident substance‑use disorders (SUDs) and related adverse events compared with those on sodium‑glucose...
Scientists Are Finally Unlocking a Cancer Treatment’s Full Potential
German hematologist Fabian Müller applied experimental CAR‑T cell therapy to a 47‑year‑old woman suffering from three severe autoimmune diseases, achieving remission and eliminating her need for transfusions. CAR‑T, originally developed for cancer, is now delivering months‑to‑years of remission in multiple...
Sleep Disorders in Rural Appalachia Nearly 6 Times the National Average
New research published in JAMA Network Open reveals that clinical sleep disorders are dramatically more common in rural Appalachia than across the United States. Among 327 adults surveyed in 12 distressed Kentucky counties, 64.9% met criteria for insomnia and 51.3%...
STAT+: 5 Years After Lupus Breakthrough, CAR-T Is Still Surprising Autoimmunity Researchers
Five years after a pioneering CAR‑T treatment rescued a teenage lupus patient, the therapy has sustained remission and reshaped expectations for autoimmune disease management. The case, led by German rheumatologist Georg Schett, proved that engineered T cells could safely target...
Top C.D.C. Official Delays Report on Covid Shot’s Effectiveness
The CDC’s acting director, Dr. Jay Bhattacharya, postponed the release of a study that showed the Covid‑19 vaccine sharply cut hospitalizations and emergency‑room visits during the previous winter. Bhattacharya cited methodological flaws, arguing the analysis painted an inaccurate picture of...
How to Choose the Right Home Healthcare Agency
Choosing the right home healthcare agency is critical for maintaining a loved one's safety, comfort, and quality of life. Agencies coordinate medical and personal support, ranging from skilled nursing to daily living assistance, and act as a communication bridge between...
Healthcare CIOs See AI Integration as a Competitive Necessity
A new Qventus report reveals a widening execution gap as health systems move from AI pilots to enterprise‑wide deployments. While 42% of respondents are actively rolling out AI across multiple use cases, only 4% have achieved measurable scale, and 74%...
CMS Updates Psychiatric and Rehab Payments
The Centers for Medicare & Medicaid Services (CMS) has released proposed FY 2027 payment updates for inpatient psychiatric facilities (IPFs) and inpatient rehabilitation facilities (IRFs). CMS suggests a 2.3% increase for IPFs and a 2.4% increase for IRFs, both lower than...
Siemens Healthineers, Onvida Health Sign 10-Year 'Value Partnership'
Siemens Healthineers and Onvida Health have signed a 10‑year Value Partnership to modernize the Yuma‑based health system’s imaging and therapy equipment. The agreement includes upgrades to CT, MRI, ultrasound and radiation therapy platforms and joint strategic planning with Siemens affiliate...
Long-Term Bimekizumab Data Confirm Sustained Efficacy, Consistent Safety in Hidradenitis Suppurativa: Steven Daveluy, MD
Long‑term data from the BE HEARD 1 and BE HEARD 2 trials show that 86.1% of hidradenitis suppurativa patients treated with bimekizumab remained flare‑free over a three‑year period. The biologic’s safety profile stayed consistent from week 16 through year 3, with no new signals detected. Early...
Eli Lilly’s Mounjaro Loses Ground to Less-Expensive Semaglutide Generics & Innovator Novo Nordisk’s Products
Eli Lilly’s tirzepatide brand Mounjaro saw sales dip to ₹114 crore in March, down from ₹135 crore in February, as low‑cost generic semaglutide entered the Indian market. The generics, launched by 13 firms across 26 SKUs, are priced 50‑80% below Novo Nordisk’s Ozempic, Wegovy...
Makena (Hydroxyprogesterone Caproate Injection) Information
The FDA’s Center for Drug Evaluation and Research has proposed withdrawing approval of Makena, a hydroxyprogesterone caproate injection originally granted accelerated approval in 2011 to reduce preterm birth risk. A confirmatory trial—four times larger than the pivotal study—failed to demonstrate...
Julia Sand & The Art of Inspiration
Anthony Guerra argues that inspiration, more than strategy or coaching, is the key driver of high‑functioning teams. He illustrates this with the historical case of President Chester A. Arthur, whose unexpected moral shift followed a series of letters from Julia Sand urging him...
'The System's Broken': Minn. EMS Faces Staffing Gaps as Calls Surge
Hennepin County’s EMS is operating below minimum staffing levels even as 911 call volume climbs 26% to nearly 100,000 annually. Union records show shifts with fewer than nine paramedics on duty when over two dozen are required, and a February...
CDRH Targets Hospital Readmissions with Home Device Innovation Challenge
The FDA’s Center for Devices and Radiological Health (CDRH) launched the Reducing Readmissions through Device Innovation for the Home Innovation Challenge to spur home‑based medical devices that can lower hospital readmissions. Nine devices will be chosen by Dec 4, 2026, and the...
Pure Indulgence Aesthetics - 723267 - 04/01/2026
The FDA issued a warning letter to Pure Indulgence Aesthetics after a December 2025 inspection revealed serious DSCSA violations. The spa dispensed significantly more Botox units than it purchased from AbbVie, suggesting use of unauthorized sources, and was found with...
Novartis Expands Community Health Programs to Close Gaps in Heart Disease and Cancer Care, Targeting 30+ Countries by 2030
Novartis announced a major expansion of its community health initiatives, aiming to operate in more than 30 countries by 2030. The rollout includes Inclusive Health Accelerators in five U.S. cities for breast and prostate cancer, Community Health Initiatives in at...
The Invisible Implementation: Why Healthcare IT Needs to Shift From Vendors to Partners
The article urges healthcare IT leaders to treat implementations as partnerships rather than vendor transactions. It stresses that successful rollouts begin weeks before the kickoff with detailed mapping of services, requirements, and dependencies. By using transparent roadmaps, parallel workstreams, and...
EClinicalWorks Launches Production Support for CMS ‘Kill the Clipboard’ Initiative
eClinicalWorks announced production support for the CMS “Kill the Clipboard” initiative, enabling paper‑less patient intake through QR‑code scanning with its eClinicalMobile app. When patients arrive, a secure QR code pulls verified medical records from interoperability networks and populates the EHR...
AI-Driven Precision Care Is the Fix for Our Health System’s Failures
Primary care physicians face chronic time constraints, often resorting to rushed exams and delayed specialist referrals that exacerbate patient outcomes. AI‑driven precision care tools act as intelligent clinical assistants, surfacing relevant chart data, suggesting differential diagnoses, and drafting evidence‑based treatment...
Amazon Pharmacy to Offer Eli Lilly’s Foundayo via Same-Day Delivery
Amazon Pharmacy announced it will dispense Eli Lilly’s newly approved oral GLP‑1 drug Foundayo, a once‑daily treatment for obesity and overweight adults. Customers can order the medication with a prescription, view real‑time availability and transparent pricing, and receive same‑day delivery...
Office of Prescription Drug Promotion (OPDP) News
The FDA’s Office of Prescription Drug Promotion issued a final guidance on Jan 6 2025 that clarifies its enforcement policy for firm‑initiated communications of scientific information on unapproved uses (SIUU) to health‑care providers. The document specifies permissible source publications—journal reprints, clinical practice...
Mount Sinai Unveils Real-Time Intraocular Pressure Monitoring in Glaucoma Surgery
Mount Sinai researchers unveiled miDOC, a micro‑interventional device that continuously measures intraocular pressure, flow, outflow facility and ocular compliance during glaucoma surgery. In the first 20 first‑in‑human cases, surgeons accessed real‑time biometric feedback and could adjust their technique on the...
Prescription Drug User Fee Amendments
The FDA sent FY2025 clean‑up and FY2026 PDUFA fee invoices, with payments due Jan 20 2026 and Nov 13 2025 respectively. FY2026 fee rates rose to $4.68 million for full applications, $2.34 million for half‑fees, and $442,213 for annual program fees. Effective Oct 1 2025 the agency will...
Avalyn Plots IPO to Push Inhaled Pulmonary Fibrosis Pipeline Through Clinic
Avalyn Pharma announced its intent to launch an IPO on Nasdaq under the ticker AVLN, though the number of shares and target raise remain undisclosed. The company will channel the proceeds into advancing its inhaled pulmonary‑fibrosis pipeline, beginning with AP01,...
Algorithm Drives Blood Pressure Control Across UC Health Centers
The University of California’s six academic medical centers deployed the UC Way Hypertension Medication Algorithm, raising blood‑pressure control from 68.5% to nearly 74% among roughly 90,000 patients. A two‑year BMJ Open Quality study showed the improvement translates to about 4,860 additional...
STAT+: Pharmalittle: We’re Reading About Top Pharma Lobbyist Stepping Down, Genes and GLP-1 Drugs, and More
Steve Ubl, longtime chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA), announced he will step down at the end of the year after more than a decade leading the industry’s primary trade group. His tenure spanned the...
Blockchain For Impact Launches $50-M Innovation Platform for Medtech Ecosystem
Blockchain For Impact (BFI) has unveiled a $50 million Innovation Full Stack platform aimed at accelerating biomedical and MedTech development in India. The initiative, anchored by the Nailwal MedTech Acceleration Hub, offers early‑stage innovators access to prototyping facilities, engineering expertise, material‑science resources, and...